{"schema_version":"secwatch.filing_event.v1","accession":"0001965040-24-000002","form_type":"8-K","ticker":"FTRE","cik":"0001965040","company_name":"Fortrea Holdings Inc.","filed_at":"2024-01-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:26.389565+00:00","generated_at":"2026-06-07T02:39:39.525715+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Fortrea reports Q4 book-to-bill >1.2x; exits 40% of TSAs; review clears trial conduct","bullets":["Book-to-bill ratio exceeded 1.2x for Q4 2023 and for first six months as an independent company.","Exited approximately 40% of Transition Services Agreements with former parent by end of 2023.","Hired a recognized AI industry expert to lead machine learning efforts.","Independent expert review found no deficit in Fortrea's conduct on two ACELYRIN clinical trials.","Select new business proposals and awards were affected by news surrounding the clinical trials."],"urls":{"canonical":"https://secwatch.observer/filing/0001965040-24-000002","json":"https://secwatch.observer/filing/0001965040-24-000002.json","markdown":"https://secwatch.observer/filing/0001965040-24-000002.md","text":"https://secwatch.observer/filing/0001965040-24-000002.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1965040/000196504024000002/0001965040-24-000002-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1965040/000196504024000002/ftre-20240108.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T02:39:39.525715+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"8ce0a56aebb0238b6eee2367878237334d5c2e71","claim":"Fortrea Holdings Inc. reported financial results for the fourth quarter of 2023.","evidence_excerpt":"Fortrea Holdings Inc. (the “Company”) announced that it delivered a book-to-bill ratio that exceeded 1.2x for the fourth quarter of 2023.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1965040/000196504024000002/0001965040-24-000002-index.htm","confidence":0.7,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the fourth quarter of 2023"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}